本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Werewolf Therapeutics, Inc.

1.05
-0.0400-3.67%
盘后1.050.00000.00%16:04 EDT
成交量:38.70万
成交额:41.35万
市值:4,711.73万
市盈率:-0.63
高:1.12
开:1.07
低:1.03
收:1.09
数据加载中...
2025/06/13

重要事件披露

Form 8-K - Current report
2025/05/16

重要事件披露

Form 8-K - Current report
2025/05/14

SEC问询函

Form CORRESP - Correspondence
2025/05/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/03/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/02/24

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/08

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report